Merck posts better-than-expected second-quarter results on Keytruda strength
Merck reported better-than-expected second-quarter revenue of $16.61 billion, driven by strong Keytruda cancer drug sales, and raised its full-year forecast.
Merck reported better-than-expected second-quarter revenue of $16.61 billion, driven by strong Keytruda cancer drug sales, and raised its full-year forecast.
Yum Brands reported that a cyclospora outbreak linked to Taco Bell caused meaningful sales damage, though early recovery signs have emerged with sales improving over recent days.
Ferrari raised its 2026 guidance after beating second-quarter expectations, citing strong demand for its luxury sports cars and a full order book through 2027.
Jersey Mike’s shares fell 6% in their initial trading on the New York Stock Exchange after the sandwich chain priced its IPO at $23 per share, raising approximately $1 billion.
Coinbase shares fell over 7% after reporting a wider-than-expected loss for the second quarter, marking its third consecutive quarter missing Wall Street revenue and earnings forecasts.
Financial sector stocks have surged recently on strong earnings and reduced concerns about private credit, with the XLF financial ETF rising 6.2% in July and reaching record highs.